1. Gilead’s Kite files for FDA approval of second CAR-T — Merck’s Keytruda gets win for triple-negative breast cancer — The House votes on the Lower Drug Cost Now Act — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

CV Therapeutics

Anonymous board for CV Therapeutics


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    1
    Views:
    3,843
  2. Anonymous
    Replies:
    3
    Views:
    6,779
  3. Anonymous
    Replies:
    5
    Views:
    8,505
  4. Anonymous
    Replies:
    1
    Views:
    3,485
  5. Anonymous
    Replies:
    0
    Views:
    3,232
  6. Anonymous
    Replies:
    4
    Views:
    5,150
  7. Anonymous
    Replies:
    1
    Views:
    4,196
  8. Anonymous
    Replies:
    1
    Views:
    3,799

Thread Display Options

Loading...